Intra-Cellular Therapies
ITCI
#1495
Rank
โ‚ฌ11.95 B
Marketcap
112,27ย โ‚ฌ
Share price
0.00%
Change (1 day)
72.61%
Change (1 year)

Intra-Cellular Therapies (ITCI) - Total assets

Total assets on the balance sheet as of December 2024 : โ‚ฌ1.16 Billion

According to Intra-Cellular Therapies's latest financial reports the company's total assets are โ‚ฌ1.16 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Intra-Cellular Therapies - Total assets on balance sheet (from 2013 to 2024)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.31 B99.38%
2023-12-31โ‚ฌ0.65 B-6.37%
2022-12-31โ‚ฌ0.70 B62.65%
2021-12-31โ‚ฌ0.43 B-25.82%
2020-12-31โ‚ฌ0.58 B160.09%
2019-12-31โ‚ฌ0.22 B-28.19%
2018-12-31โ‚ฌ0.31 B-20.54%
2017-12-31โ‚ฌ0.39 B6.28%
2016-12-31โ‚ฌ0.36 B-16.49%
2015-12-31โ‚ฌ0.44 B310.7%
2014-12-31โ‚ฌ0.10 B287.21%
2013-12-31โ‚ฌ27.84 M85.78%
2013-03-31โ‚ฌ0 M
2012-12-31โ‚ฌ14.98 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
MediciNova
MNOV
โ‚ฌ40.5 M-96.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
โ‚ฌ23.53 M-97.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.73 B-36.44%๐Ÿ‡บ๐Ÿ‡ธ USA